Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2012

01-02-2012 | Short Research Report

Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center

Authors: Haitham W. Tuffaha, Ola Abdelhadi, Suha Al Omar

Published in: International Journal of Clinical Pharmacy | Issue 1/2012

Login to get access

Abstract

Background There is a need to expand clinical pharmacy services to cover the ambulatory pediatric cancer patients. There is a paucity of published literature describing pharmacy services in this setting. Objective To describe the development, implementation and the reported interventions of a clinical pharmacy service in the outpatient pediatric hematology–oncology clinics at a comprehensive cancer center in Jordan. Methods A stepwise approach was followed to develop and implement the described service. Four goals were set for the service comprising (1) ensure safe medication use (2) improve patient and caregiver education (3) enhance efficiency in medication distribution (4) facilitate the continuity of care across the inpatient and outpatient settings. The interventions collected were categorized into four major classes: clarification, safety, therapeutic and education. Results A total of 939 interventions were reported. Safety interventions were the highest with 500 (53%), followed by education 247 (26%), clarification 113 (12%) and therapeutic 79 (9%). The most common single interventions were patient counseling 247 (26%) and chemotherapy evaluation 229 (24%). Less frequent interventions were drug interactions and adverse drug reactions with 10 (1%) each. Conclusion Developing pediatric hematology–oncology clinical pharmacy services to cover the outpatient setting is essential to ensure continuity of care and to optimize therapeutics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.PubMed
2.
go back to reference Katherine KK, Mark PO, Beverly LB. ASHP survey of ambulatory care pharmacy practice in health systems—2004. Am J Health-Syst Pharm. 2005;62:274–84. Katherine KK, Mark PO, Beverly LB. ASHP survey of ambulatory care pharmacy practice in health systems—2004. Am J Health-Syst Pharm. 2005;62:274–84.
3.
go back to reference Wong SW, Gray ES. Clinical pharmacy services in oncology clinics. J Oncol Pharm Pract. 1999;5(1):49–54. Wong SW, Gray ES. Clinical pharmacy services in oncology clinics. J Oncol Pharm Pract. 1999;5(1):49–54.
4.
go back to reference Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a haematology/oncology outpatient setting. Ann Pharmacother. 2006;40(9):1527–33.PubMedCrossRef Shah S, Dowell J, Greene S. Evaluation of clinical pharmacy services in a haematology/oncology outpatient setting. Ann Pharmacother. 2006;40(9):1527–33.PubMedCrossRef
5.
go back to reference Ruder AD, Smith DL, Madsen MT, Kass FH. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract. 2011; doi:10.1177/1078155210389216 [Epub ahead of print]. Ruder AD, Smith DL, Madsen MT, Kass FH. Is there a benefit to having a clinical oncology pharmacist on staff at a community oncology clinic? J Oncol Pharm Pract. 2011; doi:10.​1177/​1078155210389216​ [Epub ahead of print].
6.
go back to reference Valgus JM, Faso A, Gregory KM, Jarr S, Savage S, Caiola S, et al. Integration of a clinical pharmacist into the hematology–oncology clinics at an academic medical center. Am J Health Syst Pharm. 2011;68(7):613–9.PubMedCrossRef Valgus JM, Faso A, Gregory KM, Jarr S, Savage S, Caiola S, et al. Integration of a clinical pharmacist into the hematology–oncology clinics at an academic medical center. Am J Health Syst Pharm. 2011;68(7):613–9.PubMedCrossRef
7.
go back to reference Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm. 2011;68(2):143–50.PubMedCrossRef Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm. 2011;68(2):143–50.PubMedCrossRef
8.
go back to reference Lam MS. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs. Pharmacotherapy. 2011;31(2):164–92.PubMedCrossRef Lam MS. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs. Pharmacotherapy. 2011;31(2):164–92.PubMedCrossRef
9.
go back to reference Kondryn HJ, Edmondson CL, Hill J, Eden TO. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol. 2011;12(1):100–8.PubMedCrossRef Kondryn HJ, Edmondson CL, Hill J, Eden TO. Treatment non-adherence in teenage and young adult patients with cancer. Lancet Oncol. 2011;12(1):100–8.PubMedCrossRef
Metadata
Title
Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center
Authors
Haitham W. Tuffaha
Ola Abdelhadi
Suha Al Omar
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 1/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9600-4

Other articles of this Issue 1/2012

International Journal of Clinical Pharmacy 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.